A private equity firm’s unit – backed by the Rockefeller and Hyundai dynasties – has completed its growth partnership with Singapore Orthopaedic Specialists (SOS), which focuses on musculoskeletal care.

The unit is called Artemis Health Ventures, part of the Sylvan Group. (This news service has also covered events at the Sylvan Group here.)

Through the partnership, SOS will help its growth by bringing together medical professionals from across sub-specialities to provide the best-possible integrated musculoskeletal care in Singapore, it said in a statement.

SOS operates under three practices – Orthopaedics International, Sports Medicine International and Neurosurgery International. The planned expansion comes at a time when demand for such care is increasing rapidly due to the ageing population. SOS’s practices treat patients suffering from various musculoskeletal ailments such as nagging sports injuries, spine and neurosurgical problems, musculoskeletal tumours, orthopaedic trauma, and painful arthritis.

The organisation has 10 specialists in its ranks who have been serving the orthopaedic needs of the local and international community since 1995. These doctors will remain as shareholders in the enlarged company.

The Sylvan Group was founded in 2019. To date, Its maiden fund, the Sylvan Asia Growth Fund I, has invested about $140 million in four Singapore-based healthcare and pharmaceutical companies, including Artemis.

View Articles